Molecule GmbH

Molecule provides infrastructure for recording, tokenizing, and funding scientific research through blockchain technology. The platform operates as a discovery engine for tokenized science, enabling researchers to register intellectual property as liquid, onchain assets. By using modular architecture that includes smart contract wallets and NFT-based lab identities, Molecule allows scientific research to be managed, funded, and traded with transparency. The system replaces traditional, gatekept processes with a decentralized approach to intellectual property, where ownership can be shared and research outputs are accessible to a global network of funders and scientists.

This infrastructure is designed to solve inefficiencies in drug development and translational research by aligning the incentives of researchers and funders. By turning IP into a liquid asset class, Molecule seeks to decentralize the ownership, financing, and governance of biotechnology. The platform is used by stakeholders to discover licensing, co-development, and investment opportunities in novel therapeutic technologies, aiming to accelerate the transition of scientific discoveries from the laboratory to practical applications. Through its protocol-level tools and ecosystem, the company facilitates collaborative research and democratizes access to early-stage science.